Sort by
Refine Your Search
-
candidate will use a combination of microscopy, proteomics, genetic constructs, and in vitro reconstitution to study if these change in biomass density results in phase transitions in the cytoplasm and if
-
of funding. Candidates who have tenure-track offers but would like to defer and do a one-year postdoc are also welcome to apply. Basic Qualifications: Ph.D. in Statistics, Mathematics, Computer Science or a
-
molecular and phenotype data. Including code that is production-ready for dissemination to other laboratories and for diagnostic use, and the management of large-scale data. They will join a team of
-
applicants for a postdoctoral fellow position in the Laboratory of Systems Pharmacology (LSP; https://labsyspharm.org/ ), part of the Harvard Program in Therapeutic Science, at Harvard Medical School in Boston
-
to collaborate with the Department's interdisciplinary faculty —including economists, physicians, and statisticians—on projects that bridge methods, policy, and practice. This role will involve intensive analysis
-
salaried and benefits eligible. Information regarding postdoctoral fellow salary, which is determined by the number of years post PhD, and benefits can be found at https://postdoc.hms.harvard.edu/guidelines
-
Email: achoat@seas.harvard.edu Equal Opportunity Employer: Harvard is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color
-
, and statisticians—on projects that bridge methods, policy, and practice. This role will involve intensive analysis of claims data and related large administrative datasets to support policy-relevant
-
performance. For additional information regarding the PI, associated research, and project institutions, see: http://gonetowar.com https://ghsm.hms.harvard.edu/person/faculty/joseph-gone http
-
channels in both heterologous expression systems and in native neurons. The successful candidate will work with Dr. Bean and a team of post-doctoral researchers in the Bean lab to do early-stage drug